| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/13/2023 | — | Maxim Group | Downgrades | Buy → Hold | |
| 08/10/2023 | 713.01% | BTIG | $2 → $10 | Maintains | Buy |
| 05/25/2023 | 42.28% | EF Hutton | → $1.75 | Initiates Coverage On | → Buy |
| 05/18/2023 | 62.6% | BTIG | $3 → $2 | Maintains | Buy |
| 04/24/2023 | 143.9% | BTIG | $3 → $3 | Maintains | Buy |
| 03/10/2023 | 143.9% | BTIG | → $3 | Maintains | Buy |
| 02/06/2023 | 631.71% | Oppenheimer | $12 → $9 | Maintains | Outperform |
| 02/05/2023 | 184.55% | BTIG | $3.5 → $3.5 | Maintains | Buy |
| 01/05/2023 | 225.2% | Scotiabank | → $4 | Initiates Coverage On | → Sector Outperform |
| 12/12/2022 | 184.55% | BTIG | → $3.5 | Assumes | → Buy |
| 07/18/2022 | 875.61% | Oppenheimer | → $12 | Assumes | → Outperform |
| 04/07/2022 | 469.11% | BTIG | $10 → $7 | Maintains | Buy |
| 06/16/2021 | 713.01% | BTIG | → $10 | Initiates Coverage On | → Buy |
| 12/04/2020 | — | Roth Capital | Downgrades | Buy → Neutral | |
| 09/24/2020 | 1.63% | Ladenburg Thalmann | → $1.25 | Initiates Coverage On | → Buy |
| 04/08/2020 | 21.95% | Oppenheimer | → $1.5 | Initiates Coverage On | → Outperform |
What is the target price for Bionano Genomics (BNGO)?
The latest price target for Bionano Genomics (NASDAQ: BNGO) was reported by Maxim Group on November 13, 2023. The analyst firm set a price target for $0.00 expecting BNGO to fall to within 12 months (a possible -100.00% downside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bionano Genomics (BNGO)?
The latest analyst rating for Bionano Genomics (NASDAQ: BNGO) was provided by Maxim Group, and Bionano Genomics downgraded their hold rating.
When is the next analyst rating going to be posted or updated for Bionano Genomics (BNGO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bionano Genomics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bionano Genomics was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.
Is the Analyst Rating Bionano Genomics (BNGO) correct?
While ratings are subjective and will change, the latest Bionano Genomics (BNGO) rating was a downgraded with a price target of $0.00 to $0.00. The current price Bionano Genomics (BNGO) is trading at is $1.23, which is out of the analyst's predicted range.